Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, Canada.
Multi-Organ Transplantation Program, London Health Sciences Centre, London, Canada.
Am J Transplant. 2019 Mar;19(3):686-698. doi: 10.1111/ajt.15112. Epub 2018 Oct 16.
Transplantation is invariably associated with programmed cell death including apoptosis and necrosis, resulting in delayed graft function and organ rejection. We have demonstrated the contribution of necroptosis to mouse microvascular endothelial cell (MVEC) death and transplant rejection. Organ injury results in the opening of mitochondrial permeability transition pores (mPTPs), which can trigger apoptotic molecules release that ultimately results in cell death. The effect of mPTPs in the necroptotic pathway remains controversial; importantly, their role in transplant rejection is not clear. In this study, tumor necrosis factor-α triggered MVECs to undergo receptor-interacting protein kinase family (RIPK1/3)-dependent necroptosis. Interestingly, inhibition of mPTP opening could also inhibit necroptotic cell death. Cyclophilin-D (Cyp-D) is a key regulator of the mPTPs. Both inhibition and deficiency of Cyp-D protected MVECs from necroptosis (n = 3, P < .00001). Additionally, inhibition of Cyp-D attenuated RIPK3-downstream mixed-lineage kinase domain-like protein phosphorylation. In vivo, Cyp-D-deficient cardiac grafts showed prolonged survival in allogeneic BALB/c mice posttransplant compared with wild-type grafts (n = 7, P < .0001). Our study results suggest that the mPTPs may be important mechanistic mediators of necroptosis in cardiac grafts. There is therapeutic potential in targeting cell death via inhibition of the mPTP-regulating molecule Cyp-D to prevent cardiac graft rejection.
移植总是伴随着程序性细胞死亡,包括细胞凋亡和坏死,导致移植物功能延迟和器官排斥。我们已经证明坏死在小鼠微血管内皮细胞 (MVEC) 死亡和移植排斥中的作用。器官损伤导致线粒体通透性转换孔 (mPTP) 的开放,这可以触发凋亡分子的释放,最终导致细胞死亡。mPTP 在坏死途径中的作用仍存在争议;重要的是,它们在移植排斥中的作用尚不清楚。在这项研究中,肿瘤坏死因子-α触发 MVEC 发生受体相互作用蛋白激酶家族 (RIPK1/3) 依赖性坏死。有趣的是,抑制 mPTP 的开放也可以抑制坏死性细胞死亡。亲环素-D (Cyp-D) 是 mPTP 的关键调节因子。Cyp-D 的抑制和缺乏均可保护 MVEC 免受坏死(n = 3,P <.00001)。此外,抑制 Cyp-D 可减弱 RIPK3 下游混合谱系激酶结构域样蛋白的磷酸化。在体内,与野生型移植物相比,Cyp-D 缺陷型心脏移植物在同种异体 BALB/c 小鼠移植后存活时间延长(n = 7,P <.0001)。我们的研究结果表明,mPTP 可能是心脏移植物中坏死的重要机制介体。通过抑制 Cyp-D 等调节 mPTP 的分子来靶向细胞死亡可能具有预防心脏移植物排斥的治疗潜力。